BiotechTube

Maxigesic® IV

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Postoperative Pain

Conditions

Postoperative Pain

Trial Timeline

Jul 22, 2019 → Jul 7, 2020

NCT ID
NCT04005755

About Maxigesic® IV

Maxigesic® IV is a phase 3 stage product being developed by AFT Pharmaceuticals for Postoperative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT04005755. Target conditions include Postoperative Pain.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT04005755Phase 3Completed

Competing Products

20 competing products in Postoperative Pain

See all competitors
ProductCompanyStageHype Score
Naldemedine + PlaceboShionogiPhase 2
52
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVEisaiApproved
85
Lemborexant 5 mg + Control (placebo) groupEisaiPhase 2
52
Ondansetron + PalonosetronEisaiPhase 2
52
AQUAVAN (fospropofol disodium; GPI 15715 )EisaiPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2/3
65
Levofloxacin Ophthalmic + CefuroximeSanten PharmaceuticalPhase 1/2
41
Levofloxacin Ophthalmic Product + Moxifloxacin Ophthalmic SolutionSanten PharmaceuticalPhase 1/2
41
Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparationJiangsu Hengrui MedicinePhase 1
33
SHR0410 Injection + SHR0410 Injection + PlaceboJiangsu Hengrui MedicinePhase 3
77
SHR8554 InjectionJiangsu Hengrui MedicinePhase 1
33
EsomeprazoleAstraZenecaApproved
85
deep neuromuscular blockMerckPre-clinical
23
Rolapitant Dose 1 + Rolapitant Dose 2 + Rolapitant Dose 3 + Rolapitant Dose 4 + Ondansetron + PlaceboMerckPhase 2
52
MK0966, rofecoxib + Comparator: valdecoxibMerckPhase 3
77
Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, PlaceboMerckApproved
85
MK0719MerckPhase 2
52
Sugammadex + NeostigmineMerckApproved
85
MK0869, aprepitant + Comparator: ondansetron IVMerckPhase 3
77

Other Products from AFT Pharmaceuticals

Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion)Phase 3
69
Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IVPhase 3
69
Maxigesic 325 + Acetaminophen + Ibuprofen + PlaceboPhase 3
69
Acetaminophen + Maxigesic 325 + Ibuprofen + PlaceboPhase 3
69
Combogesic® tablets + Acetaminophen 500mg + PlaceboPhase 3
69